Neonatal opioid withdrawal syndrome (NOWS) has risen in prevalence from 1.2 per 1000
births in 2000 to 5.8 per 1000 births in 2012. Symptoms in neonates may include high …

Background Children born to opioid-dependent mothers are at risk of adverse
neurodevelopment. The magnitude of this risk remains inconclusive. Objective To conduct a …

Importance The opioid epidemic increasingly affects pregnant women and developing
fetuses, resulting in high rates of neonatal abstinence syndrome. However, longitudinal …

The objectives of this project were to systematically review the impact of mother–infant
interaction on the development of infants 12 months or younger and determine factors that …

Objective To characterize cognitive function in young children under 3 years of age over the
past decade, and test whether children exhibit different cognitive development profiles …

The past decade has seen a drastic rise in the number of infants exposed to opioids in utero.
It is unclear what lasting effect this exposure may have on these children. Animal models of …

Background: A growing body of research underlines that interpersonal trauma in childhood
leads to heightened susceptibility for substance use disorders (SUDs) in later life. Little …

The abuse of prescription opioids and heroin by women of childbearing age over the past
decade has resulted in a five-fold increase in the number of infants born opioid-dependent …

Aim This systematic review aims to estimate the relationship between prenatal exposure to
opioids and neurodevelopmental outcomes and examines potential sources of …

Background While use of prescription opioids and medication assisted therapy (MAT) for
opioid use disorder in pregnancy, as well as the incidence of neonatal opioid withdrawal …